Skip to main content

vicc

Discovery of aggressive cancer cell types by Vanderbilt researchers made possible with machine learning techniques

Jun. 24, 2020—Rebecca Ihrie and Jonathan Irish are leading the development of machine learning applications for brain cancer research.

Read more


Career enhancement funding opportunity: VICC SPORE in Breast Cancer

Jun. 11, 2020—The VICC SPORE in Breast Cancer announces a Career Enhancement Program funding opportunity that aims to attract, develop and mentor promising basic, translational and population-based research scientists, including physician scientists, into breast cancer research.

Read more


Developmental research funding opportunity: VICC SPORE in Breast Cancer

Jun. 11, 2020—The VICC SPORE in Breast Cancer announces a Developmental Research Program pilot funding opportunity focused on catalyzing innovative and transformative breast cancer-related projects that promote discoveries in basic and translational research focused on metastatic disease.

Read more


Wilson awarded Komen breast cancer research grant

Sep. 25, 2019—An engineering professor has received financial support from Susan G. Komen for breast cancer research. His project is among 60 grants totaling $26 million awarded to researchers nationwide. Those initiatives are focused on improving outcomes for metastatic breast cancer, reducing disparities in survivorship and developing new, more effective treatments. John T. Wilson, assistant professor of...

Read more


Investigators map genomic landscape of very rare cancer

Feb. 28, 2019—A team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer.

Read more


Discovery of new “checkpoint” points to new cancer immunotherapy option

Feb. 21, 2019—An international team involving Vanderbilt researchers has discovered that a new “checkpoint” protein on immune system cells is active in tumors, and that blocking it — in combination with other treatments — is a successful therapeutic approach in mouse models of cancer.

Read more


Research explores link between stem cell transplant, diabetes

Jan. 17, 2019—Brian Engelhardt is studying why as many as 50 percent of stem cell transplant recipients develop diabetes.

Read more


VICC experts to discuss high risk breast cancer at free seminar June 6

May. 26, 2017—Vanderbilt-Ingram Cancer Center (VICC), in collaboration with the Hereditary Cancer Program and the Vanderbilt Breast Center, is hosting a free seminar, “Are You at High Risk for Breast Cancer?”

Read more


VICC Annual Scientific Retreat slated for May 4

Apr. 20, 2017—Leading cancer investigators from several prominent universities and laboratories will headline the 2017 Vanderbilt-Ingram Cancer Center (VICC) Annual Scientific Retreat May 4.

Read more


Annual Meharry–Vanderbilt–TSU Cancer Partnership retreat April 8

Mar. 23, 2017—The Meharry Medical College, Vanderbilt-Ingram Cancer Center (VICC) and Tennessee State University (TSU) Cancer Partnership will host its 16th Annual Cancer Retreat on April 8.

Read more


Know the facts about ovarian cancer

Sep. 16, 2016—Listening to the body and being aware of individual risks are especially important when it comes to ovarian cancer. Vanderbilt–Ingram Cancer Center provides the facts.

Read more


VICC joins other major cancer centers in HPV vaccine campaign

Feb. 4, 2016—In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in recommending increased HPV vaccination for the prevention of cancer.

Read more


VIEW MORE EVENTS >